Boston to Acquire Baylis for ~$1.75B

Shots: Boston has entered into a definitive agreement to acquire Baylis for $1.75B up front. The transaction is anticipated to close in Q1’22 The acquisition will bolster Boston’s electrophysiology and structural heart product portfolios with the addition of Baylis’ platforms i.e., NRG and VersaCross Transseptal that uses radiofrequency to access the left side of the heart …

Boston to Acquire Baylis for ~$1.75B Read More »